MS Sherpa offers a smartphone‑based home monitoring platform for people with multiple sclerosis and their care teams. Users perform validated tests to objectively track symptoms over time, generating reliable data that can be shared with clinicians to inform personalized treatment decisions. The tool is developed in collaboration with academic hospitals and is being expanded to other conditions such as Parkinson’s disease.
Funding
Funding not disclosed
Founders
Product
Problem
People with multiple sclerosis often lack convenient, objective ways to monitor symptom changes over time, making it difficult for patients and neurologists to assess disease progression and adjust treatment promptly.
Solution
MS Sherpa provides a smartphone‑based home monitoring platform that lets patients perform validated symptom tests in their own environment. The app records test results, visualizes trends, and sends secure data to the treating neurologist. Personalized reminders help ensure regular testing, while the collected longitudinal data enable clinicians to make more informed, individualized treatment decisions. The solution is developed in collaboration with AmsterdamUMC and integrated into clinical practice through the Upendo network, ensuring medical-grade validation and real‑world applicability.
Target Audience
Primary users are individuals diagnosed with multiple sclerosis and their neurologists or MS treatment teams seeking objective, home‑based disease monitoring.
Features
- Validated MS symptom tests accessible via a standard smartphone
- Automated, customizable reminders to promote consistent self‑testing
- Longitudinal data visualization for patients and clinicians
- Secure data sharing with neurologists through encrypted transmission
- Integration with clinical workflows via the Upendo platform
- Academic partnership with AmsterdamUMC for ongoing validation